Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for ...

American air power has been deployed several times to "establish democracy" and fight terrorism in the Middle East. In 1990, ...

AI-powered systems can help manage energy grids, building temperatures and predict weather to store and use energy more ...

The General Dynamics F-111 “Aardvark,” born from the 1960s TFX program, was a groundbreaking tactical strike aircraft and the ...

Delivery of the F-111 to the Royal Australian Air Force was held up until General Dynamics could iron out a fatal flaw in the ...

Aardvark Sports Shop in Bethlehem hosts Striding with Pride in collaboration with Allentown’s Bradbury-Sullivan LGBT ...

Wisconsin paper manufacturers say the industry moved away from using PFAS, known as 'forever chemicals' in their production years ago.

Investment in San Diego County startups slowed in the first quarter of the year with fundings falling 46% compared to a year ...

According to TipRanks.com, Ulz is a 1-star analyst with an average return of -0.7% and a 42.5% success rate. Ulz covers the Healthcare sector, focusing on stocks such as Aardvark Therapeutics, Inc., ...

The new Telegram trading bot Snorter Token ($SNORT) has now raised over $650,000 in early funding – less than two weeks since launching its ICO.

The mean of analysts' price targets for Aardvark Therapeutics, Inc. (AARD) points to an 180.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...